CNBX Pharmaceuticals Inc.

10-Q Quarter ended 2026-05-31 Jun 24, 2026 10-Q Quarter ended 2026-02-28 Apr 14, 2026 8-K Entered a material agreement Mar 17, 2026 10-Q Quarter ended 2025-11-30 Jan 14, 2026 10-K Fiscal year ended 2025-08-31 Dec 1, 2025 10-Q Quarter ended 2025-05-31 Jul 14, 2025 10-Q Quarter ended 2025-02-28 Apr 14, 2025 8-K Entered a material agreement Jan 30, 2025 10-Q Quarter ended 2024-11-30 Jan 13, 2025 10-K Fiscal year ended 2024-08-31 Nov 29, 2024 10-Q Quarter ended 2024-05-31 Jul 15, 2024 10-Q Quarter ended 2024-02-29 Apr 16, 2024 8-K Changed accountants Mar 22, 2024 10-Q Quarter ended 2023-11-30 Jan 12, 2024 10-K Fiscal year ended 2023-08-31 Nov 30, 2023 10-Q Quarter ended 2023-05-31 Jul 14, 2023 10-Q Quarter ended 2023-02-28 Apr 14, 2023 8-K Director or officer change Feb 8, 2023 10-Q Quarter ended 2022-11-30 Jan 13, 2023 8-K Director or officer change Dec 29, 2022 10-K Fiscal year ended 2022-08-31 Nov 30, 2022 8-K Director or officer change Jul 25, 2022 10-Q Quarter ended 2022-05-31 Jul 14, 2022 8-K Amended charter or bylaws May 13, 2022 10-Q Quarter ended 2022-02-28 Apr 12, 2022 8-K Amended charter or bylaws; Other events Mar 28, 2022 8-K Entered a material agreement; Took on a direct financial obligation Mar 16, 2022 8-K Entered a material agreement Feb 17, 2022 10-Q Quarter ended 2021-11-30 Jan 13, 2022 10-K Fiscal year ended 2021-08-31 Nov 29, 2021 8-K Director or officer change Nov 19, 2021 8-K Director or officer change Sep 13, 2021 8-K Director or officer change Jul 19, 2021 10-Q Quarter ended 2021-05-31 Jul 14, 2021 8-K Director or officer change Jul 6, 2021 8-K Entered a material agreement; Item 5.04 Apr 28, 2021 10-Q Quarter ended 2021-02-28 Apr 14, 2021 10-Q Quarter ended 2020-11-30 Jan 14, 2021 8-K Entered a material agreement Dec 21, 2020 8-K Regulation FD disclosure Nov 16, 2020